| Price | 80.00p on 03-12-2025 at 10:52:42 |
|---|---|
| Change | 0.00p 0% |
| Buy | 81.00p |
| Sell | 79.00p |
| Last Trade: | Sell 25,000.00 at 79.25p |
| Day's Volume: | 706,509 |
| Last Close: | 80.00p |
| Open: | 79.50p |
| ISIN: | GB00BYYW9G87 |
| Day's Range | 79.50p - 80.00p |
| 52wk Range: | 27.25p - 83.20p |
| Market Capitalisation: | £346.93m |
| VWAP: | 79.78058p |
| Shares in Issue: | 433.66m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Avacta Group (AVCT) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 25,000 | 79.25p | Ordinary |
10:52:40 - 03-Dec-25 |
| Sell* | 25,000 | 79.80p | Ordinary |
10:52:22 - 03-Dec-25 |
| Sell* | 61 | 79.80p | Ordinary |
10:48:44 - 03-Dec-25 |
| Sell* | 2,500 | 79.825p | Ordinary |
10:43:36 - 03-Dec-25 |
| Sell* | 620 | 79.825p | Ordinary |
10:35:54 - 03-Dec-25 |
| Sell* | 172 | 79.204p | Ordinary |
10:09:21 - 03-Dec-25 |
| Sell* | 258 | 79.20p | Ordinary |
09:58:47 - 03-Dec-25 |
| Sell* | 8,423 | 79.846p | Ordinary |
09:58:44 - 03-Dec-25 |
| Sell* | 10,000 | 79.85p | Ordinary |
09:58:03 - 03-Dec-25 |
| Sell* | 6,000 | 79.40p | Ordinary |
09:54:11 - 03-Dec-25 |
Avacta Group (AVCT) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 3rd Nov 2025 8:24 am | RNS | Completion of Placing and TVR |
| 27th Oct 2025 5:39 pm | RNS | Block Listing Six Monthly Return |
| 27th Oct 2025 7:00 am | RNS | Avacta presents preclinical data at AACR-NCI-EORTC |
| 23rd Oct 2025 5:00 pm | RNS-R | Notice of Investor Presentation |
| 20th Oct 2025 7:01 am | RNS | Equity fundraise of £16 million |
| 20th Oct 2025 7:00 am | RNS | Avacta Presents Phase 1a Data for Faridoxorubicin |
| 13th Oct 2025 7:00 am | RNS | Avacta to present data at EORTC-NCI-AACR |
| 30th Sep 2025 7:00 am | RNS | Interim Half Year Results 2025 |
| 15th Sep 2025 7:00 am | RNS | Notice of Interim Results |
| 9th Sep 2025 7:00 am | RNS-R | Shortlisted for AIM Awards Technology of the Year |
